000			03851nam a22003975i 4500
001			100096
003			DE-He213
005			20230110040205.0
007			cr nn 008mamaa
008			170901s2018 gw | s |||| 0|eng d
020			_a9783319605708 _9
024	7		_a10.1007/978-3-319-60570-8 _2doi
040			_aES-MaUEC _bspa
050		4	_aRC655.49 _bT443 2018 EB
245	1	4	_aThe Bethesda System for Reporting Thyroid Cytopathology: _bDefinitions, Criteria, and Explanatory Notes _cedited by Syed Z. Ali, Edmund S. Cibas.
250			_a2nd edition
264		1	_aCham _bSpringer International Publishing _c2018
300			_a1 recurso en línea (XV, 236 páginas 224 ilustraciones a color)
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
505	0		_aOverview of Diagnostic Terminology and Reporting -- Nondiagnostic/Unsatisfactory -- Benign -- Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance -- Follicular Neoplasm/Suspicious for a Follicular Neoplasm -- Follicular Neoplasm, Hürthle Cell (Oncocytic) Type/Suspicious for a Follicular Neoplasm, Hürthle Cell (Oncocytic) Type -- Suspicious for Malignancy -- Papillary Thyroid Carcinoma, Variants, and Related Tumors -- Medullary Thyroid Carcinoma -- Poorly Differentiated Thyroid Carcinoma -- Undifferentiated (Anaplastic) Carcinoma and Squamous Cell Carcinoma of the Thyroid -- Metastatic Tumors, Lymphomas, and Rare Tumors of the Thyroid.
520	3		_a The first edition of The Bethesda System for Reporting Thyroid Cytopathology was published in 2010 and has greatly influenced the practice of thyroid cytopathology. The terminology proposed and illustrated in this text has been widely adopted not only in the U.S. but also abroad. It has become an essential text for pathology trainees and practicing pathologists examining thyroid fine needle aspiration (FNA) specimens. Since 2010, there have been a number of important advances in the management of patients with nodular thyroid disease and in the understanding of the biology of thyroid cancer. This new edition includes these advances that impact terminology for reporting thyroid cytopathology. In particular, it incorporates a discussion of the recently implemented and now widespread use of molecular testing of thyroid FNA samples, which has transformed the management of patients with nodular thyroid disease in the U.S.. In addition, this edition accommodates the recent changes to the classification of thyroid cancer, most notably the introduction of a new thyroid diagnosis, that of "non-invasive follicular tumor with papillary-like nuclear features (NIFTP)". Thoroughly revised and updated, The Bethesda System for Reporting Thyroid Cytopathology, Second Edition will provide the reader with a unified approach to diagnosing and reporting thyroid FNA interpretations. It serves as a reference guide not just for pathologists, but also endocrinologists, surgeons, and radiologists.
650		7	_aPatología _2embne _9138489
650		7	_aEndocrinología _2embne _9139372
650		7	_aTiroides
700	1		_aAli, Syed Z. _eeditor literario _0http://id.loc.gov/authorities/names/n2007181685 _0http://viaf.org/viaf/16685583
700	1		_aCibas, Edmund S. _eeditor literario _0http://id.loc.gov/authorities/names/n95801266 _0http://viaf.org/viaf/11563726
776	0	8	_iEdición impresa: _z9783319605692
776	0	8	_iEdición impresa: _z9783319605715
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-60570-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490	0		_aMedicine (Springer-11650)
988			_aSpringer_Medicine_2018
998			_b01/2019 _dz _ep _feng _ggw _h0
999			_c100096 _d100096 _x1